pre-update Archives

Press Release

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. （纳斯达克股票代码：CERT), a global leader…

Danielle Pillsbury2023 年 10 月 11 日

Publication

人工智能应用的监管举措：规范性撰写的影响

医学撰写 | Volume 32, Issue 3 - Artificial Intelligence and Machine LearningAuthor: Anjana Bose…

Danielle Pillsbury2023 年 10 月 11 日

Announcement

Certara 收购 Formedix LLC 旨在提高临床试验数据标准化，加快研究设计、分析和递交时间

Formedix ryze cloud based clinical metadata repository and SDTM automation suite and Certara Pinnacle 21…

Danielle Pillsbury2023 年 10 月 10 日

博客

扩大规模和批准后变更 (SUPAC) 指导文件是否仍适用于药物开发人员？

Do you remember the 1990s? The Soviet Union fell, Friends was the most popular TV…

Danielle Pillsbury2023 年 10 月 6 日

Conference

GMP 2024 Symposium

Danielle Pillsbury2023 年 10 月 5 日

Announcement

Certara 推出生命科学专用 GPT 平台 Certara.AI

Certara.AI Improves Drug Research & Development Processes with Secure, Client-Specific, A.I. Applications PRINCETON, N. J.—October…

Danielle Pillsbury2023 年 10 月 5 日

Publication

利用定量系统药理学模型分析神经退行性病变中抗 Tau 和抗突触核蛋白抗体的临床失败案例

Hugo Geerts, Silke Bergeler, Mike Walker, Piet van der Graaf, Jean-Philippe Courade. Sci Rep. 2023…

Danielle Pillsbury2023 年 10 月 5 日

Article

How Modeling Can Help to Improve Children’s Access to Properly Evaluated Medications

Regulatory guidance paves the way to address ethical concerns in pediatric trials, and how additional…

Danielle Pillsbury2023 年 10 月 5 日

On-Demand Webinar

Clinical Pharmacology Issues That Can Lead to Approvability Problems for Your Drug

临床药理信息占药品说明书的 50% 以上。Inadequate clinical pharmacology development…

Danielle Pillsbury2023 年 10 月 4 日

Announcement

Certara Launches CoAuthor, a Regulatory and Medical Writing Tool

Using AI to gain efficiencies for medical writers PRINCETON, N. J.— 2023 年 10 月 3 日— Certara,…

Danielle Pillsbury2023 年 10 月 3 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

pre-update

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

人工智能应用的监管举措：规范性撰写的影响

Certara 收购 Formedix LLC 旨在提高临床试验数据标准化，加快研究设计、分析和递交时间

扩大规模和批准后变更 (SUPAC) 指导文件是否仍适用于药物开发人员？

GMP 2024 Symposium

Certara 推出生命科学专用 GPT 平台 Certara.AI

利用定量系统药理学模型分析神经退行性病变中抗 Tau 和抗突触核蛋白抗体的临床失败案例

How Modeling Can Help to Improve Children’s Access to Properly Evaluated Medications

Clinical Pharmacology Issues That Can Lead to Approvability Problems for Your Drug

Certara Launches CoAuthor, a Regulatory and Medical Writing Tool

订阅时事通讯

快捷链接

解决方案

联系我们